Scientists hunt for hidden causes of drug resistance in lung cancer
NCT ID NCT07122882
First seen Mar 21, 2026 · Last updated Apr 29, 2026 · Updated 10 times
Summary
This study looks at why some lung cancers stop responding to targeted pills called tyrosine kinase inhibitors. Researchers will use advanced genetic testing on tumor samples from 40 patients to find hidden changes that cause resistance. The goal is to discover new ways to overcome resistance and improve treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ROS1 FUSION POSITIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chang Gung Memorial Hospital Linkou Branch
Taoyuan District, 333, Taiwan
Conditions
Explore the condition pages connected to this study.